MicroPort NeuroScientific Sets Board Meeting to Approve 2025 Results and Consider Final Dividend

MicroPort NeuroTech Limited ( (HK:2172) ) has issued an update.

MicroPort NeuroScientific Corporation has scheduled a board meeting for 25 March 2026 to review and approve the group’s final results for the financial year ended 31 December 2025. The board will also consider the potential payment of a final dividend and attend to other corporate matters at the meeting.

The announcement signals the upcoming disclosure of the company’s annual financial performance, which will be closely watched by investors for indications of operational progress and capital return policy. Any decision on a final dividend could influence shareholder returns and reflect management’s confidence in the group’s financial health and future prospects.

The most recent analyst rating on (HK:2172) stock is a Buy with a HK$13.00 price target. To see the full list of analyst forecasts on MicroPort NeuroTech Limited stock, see the HK:2172 Stock Forecast page.

More about MicroPort NeuroTech Limited

MicroPort NeuroScientific Corporation is a Cayman Islands-incorporated company listed in Hong Kong under stock code 2172. The group operates in the neurotechnology and medical device space through its subsidiaries, focusing on products and solutions for neurological conditions within the broader healthcare sector.

Average Trading Volume: 6,617,423

Technical Sentiment Signal: Hold

Current Market Cap: HK$6.54B

See more insights into 2172 stock on TipRanks’ Stock Analysis page.